Epstein David M. 4

4 · Black Diamond Therapeutics, Inc. · Filed Jun 28, 2023

Insider Transaction Report

Form 4
Period: 2023-06-27
Epstein David M.
DirectorSee Remarks
Transactions
  • Sale

    Common Stock

    2023-06-27$6.70/sh25,000$167,500671,423 total
Holdings
  • Common Stock

    (indirect: See footnote)
    23,090
  • Common Stock

    (indirect: See footnote)
    104,449
  • Common Stock

    (indirect: See footnote)
    16,579
  • Common Stock

    (indirect: See footnote)
    16,579
  • Common Stock

    (indirect: See footnote)
    104,449
Footnotes (6)
  • [F1]Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of December 29, 2022.
  • [F2]Shares held by wife.
  • [F3]Shares held by David M. Epstein 2019 Trust For Elle. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Elle and may be deemed to beneficially own these securities.
  • [F4]Shares held by David M. Epstein 2019 Trust For Zoe. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Zoe and may be deemed to beneficially own these securities.
  • [F5]Shares held by David M. Epstein 2019 Trust For Robert. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Robert and may be deemed to beneficially own these securities.
  • [F6]Shares held by David M. Epstein 2019 Trust For Shelley. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Shelley and may be deemed to beneficially own these securities.

Documents

1 file
  • 4
    form4-06282023_080616.xmlPrimary